Consistent with our results, in a gene ontology annotation study of the ALDH1 family [39], HBV–related HCC patients who showed high ALDH1L1 gene expression had superior clinical outcome, with a 57–month recurrence–free survival. This evidence concerns the gene ALDH1A1 and hepatocellular carcinoma.